GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION

GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION

Aim. To reveal the association of hereditary specifics of inflammatory factors with the adverse risk in atrial fibrillation (AF).Material and methods. Totally 258 patients studied (68,5±0,67 y. o.) with nonvalvular AF, recording the events as ischemic stroke, myocardial infarction, venous and arteri...

Full description

Bibliographic Details
Main Authors:	I. V. Zotova, A. N. Brovkin, E. N. Fattakhova, A. N. Nikitin, V. V. Nosikov, V. A. Brazhnik, D. A. Zateyshchikov
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-10-01
Series:	Российский кардиологический журнал
Subjects:	atrial fibrillation inflammation factors polymorphism interleukin 6 receptor gene polymorphism stroke risk thrombosis risk
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/295

Similar Items

Role of AGTR1 A/C polymorphism in the development of atrial fibrillation
by: A V Kuskaeva, et al.
Published: (2017-09-01)

POLYMORPHISM OF THE INTERLEUKIN-6, INTERLEUKIN-10, SUPEROXIDE DISMUTASE AND ANGIOTENSIN CONVERTING ENZYME GENES, AND THE RISK OF ATRIAL FIBRILLATION AFTER CARDIOSURGERY
by: O. A. Rubanenko, et al.
Published: (2016-10-01)

Correlation between HCN4 gene polymorphisms and lone atrial fibrillation risk
by: Xiao-Hong Li, et al.
Published: (2019-12-01)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
by: Ascensión M. de los Reyes-García, et al.
Published: (2023-02-01)

Thromboembolic risk factors and predictors of left atrial appendage thrombosis in Far North patients with nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2021-11-01)

LABORATORY AND GENETIC PREDICTION OF THE RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH CORONARY HEART DISEASE
by: D. I. PANCHENKO, et al.
Published: (2017-05-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
by: Shuxin Hou, et al.
Published: (2016-01-01)

PREDICTING THE RISK OF ATRIAL FIBRILLATION AND CORONARY HEART DISEASE DEVELOPMENT WITH MUTATION OF HEMOSTASIS SYSTEM GENES
by: D. I. Panchenko, et al.
Published: (2018-10-01)

ATRIAL FIBRILLATION ONSET RISK IN PATIENTS WITH METABOLIC SYNDROME: PROSPECTIVE STUDY
by: A. I. Olesin, et al.
Published: (2014-12-01)

Using the ORACLE Risk Score to Assess Hemorrhagic Risk in Patients with Acute Coronary Syndrome and Atrial Fibrillation
by: V. A. Brazhnik, et al.
Published: (2021-03-01)

The role of single-nucleotide polymorphism rs10824026 of the SYNPO2L gene in the development of atrial fibrillation in a study in the East-Siberian population
by: Kseniia Yu. Shishkova, et al.
Published: (2019-12-01)

Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review
by: Meng-Fei Wang, et al.
Published: (2023-04-01)

Thromboembolic risk stratification in atrial fibrillation—beyond clinical risk scores
by: Darryl Wan, et al.
Published: (2021-06-01)

The role of polymorphisms in genes that regulate neurohumoral systems in patients with atrial fibrillation
by: I. M. Fushtei, et al.
Published: (2019-06-01)

Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis
by: A. A. Sokolova, et al.
Published: (2022-07-01)

RISK FACTORS AND MECHANISMS OF ATRIAL FIBRILLATION DEVELOPMENT IN ATHLETES
by: S. A. Bondarev, et al.
Published: (2020-07-01)

Association of gene polymorphism at atrial fibrillation: A literature review
by: Dana Taizhanova, et al.
Published: (2021-01-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

GENETIC PREDICTORS FOR CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Shulman, et al.
Published: (2014-10-01)

Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
by: Maurizio Giuseppe Abrignani, et al.
Published: (2015-11-01)

Is endothelin gene polymorphism associated with postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting?
by: Ira Dhawan, et al.
Published: (2017-01-01)

Biomarkers of prothrombotic state in atrial fibrillation
by: CAMELIA C. DIACONU
Published: (2021-12-01)

Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true
by: Yu. A. Bunin, et al.
Published: (2016-09-01)

Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation
by: Xunwei Deng, et al.
Published: (2021-09-01)

Current Predictors of Atrial Fibrillation Progression
by: V. I. Podzolkov, et al.
Published: (2019-05-01)

Ibrutinib in patients with atrial fibrillation – the challenge of thromboembolic prophylaxis
by: Ciuculete Denisa-Corina, et al.
Published: (2021-09-01)

Fibrosis biomarkers as predictors of left atrial appendage thrombosis in patients with nonvalvular atrial fibrillation
by: T. P. Gizatulina, et al.
Published: (2022-08-01)

Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative?
by: I. A. Zaigraev, et al.
Published: (2023-05-01)

Association Between rs2200733 Polymorphism of PITX2 Gene and the Risk of Atrial Fibrillation
by: Yin Shen Han, et al.
Published: (2023-03-01)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
by: Ying Wang, et al.
Published: (2019-11-01)

Aldehyde Dehydrogenase 2 Ameliorates Chronic Alcohol Consumption-Induced Atrial Fibrillation through Detoxification of 4-HNE
by: Lung-An Hsu, et al.
Published: (2020-09-01)

Predictors of spontaneous echo contrast and left atrial appendage thrombosis in nonvalvular atrial fibrillation
by: N. Yu. Khorkova, et al.
Published: (2020-08-01)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016-06-01)

Differential Association of Cx37 and Cx40 Genetic Variants in Atrial Fibrillation with and without Underlying Structural Heart Disease
by: Sebastian Carballo, et al.
Published: (2018-01-01)

Epicardial fat and left atrial appendage thrombosis in patients with persistent atrial fibrillation
by: V. V. Mazur, et al.
Published: (2024-04-01)

Serum Fibrinogen and Renal Dysfunction as Important Predictors of Left Atrial Thrombosis in Patients with Atrial Fibrillation
by: Karlo Golubić, et al.
Published: (2023-09-01)

Mid-Term Feasibility of Percutaneous Left Atrial Appendage Occlusion in Elderly Patients with Non-Valvular Atrial Fibrillation
by: Nobuyuki Fukuda, et al.
Published: (2023-09-01)

The research of ion channel‐related gene polymorphisms with atrial fibrillation in the Chinese Han population
by: Xiumin Liu, et al.
Published: (2019-08-01)

Association of acetaldehyde dehydrogenase 2 rs671 polymorphism with the occurrence and progression of atrial fibrillation
by: Junye Ge, et al.
Published: (2022-11-01)

Association Between TCF21 Gene Polymorphism with the Incidence of Paroxysmal Atrial Fibrillation and the Efficacy of Radiofrequency Ablation for Patients with Paroxysmal Atrial Fibrillation
by: Zhang X, et al.
Published: (2022-05-01)